Skip to main content
. 2011 Dec 29;24(3):575–582. doi: 10.1007/s10811-011-9766-0

Table 3.

Comparison of comprehensive metabolic panel results from phase I and II

Phase I Phase II Reference values
Baseline N = 9 3 Weeks N = 9 Baseline N = 5 3 Weeks N = 5 3 Months N = 5
Mean ± SE Mean ± SE Mean ± SE Mean ± SE Mean ± SE
Glucose (mg dL−1) 87 ± 4 91 ± 6a 87 ± 5 91 ± 5 96 ± 6b 65–99 mg dL−1
Blood urea nitrogen (BUN) (mg dL−1) 11 ± 1 12 ± 1 11 ± 1 12 ± 2 10 ± 1 5–26 mg dL−1
Creatinine (mg dL−1) 0.9 ± 0.0 0.9 ± 0.5 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.5–1.5 mg dL−1
BUN/creatinine ratio 12 ± 1 14 ± 1 12 ± 2 14 ± 2 12 ± 2 8–27
Sodium (mmol L−1) 139 ± 0.4 139 ± 1 139 ± 1 139 ± 1 140 ± 1 135–148 mmol L−1
Potassium (mmol L−1) 3.9 ± 0.1 4.3 ± 0.1 3.9 ± 0.1 4.3 ± 0.1 4.0 ± 0.1 3.5–5.5 mmol/L
Chloride (mmol L−1) 105 ± 1 103 ± 1 105 ± 1 103 ± 1 103 ± 1 96–109 mmol L−1
Carbon dioxide, total (mmol L−1) 24 ± 1 24 ± 1 24 ± 2 24 ± 1 24 ± 1 20–32 mmol L−1
Calcium (mg dL−1) 9.4 ± 0.2 9.4 ± 0.1 9.4 ± 0.3 9.4 ± 0.1 9.4 ± 0.2 8.5–10.6 mg dL−1
Protein, total (g dL−1) 8.5 ± 0.3 8.4 ± 0.3 8.5 ± 0.3 8.4 ± 0.2 8.3 ± 0.3 6.0–8.5 g dL−1
Albumin (g dL−1) 4.0 ± 0.1 4.0 ± 0.1 4.0 ± 0.1 4.0 ± 0.1 3.9 ± 0.1 3.5–5.5 g dL−1
Globulin(g dL−1) 4.4 ± 0.4 4.4 ± 0.3 4.4 ± 0.3 4.4 ± 0.3 4.4 ± 0.3 1.5–4.5 g dL−1
A/G ratio 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9–2.5
Bilirubin, total (mg dL−1) 0.3 ± 0.0 0.4 ± 0.1 0.3 ± 0 0.4 ± 0.1 0.4 ± 0.0 0.1–1.2 mg dL−1
ALP (IU L−1) 85 ± 12 82 ± 18 85 ± 4 82 ± 6 89 ± 6 25–150 IU L−1
AST (IU L−1) 29 ± 4 29 ± 3 29 ± 4 29 ± 3 29 ± 4 0–40 IU L−1
ALT (IU L−1) 24 ± 5 25 ± 5 24 ± 5 25 ± 6 26 ± 9 0–40 IU L−1

Mean ± SE mean ± standard error, BUN blood urea nitrogen, ALP alkaline phosphatase, AST aspartate transaminase, ALT alanine transaminase

aOne subject excluded because not fasting; n = 8

bOne subject excluded because not fasting; n = 4